Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Hospital Bispebjerg and Frederiksberg clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Denmark and Brazil registers with University Hospital Bispebjerg and Frederiksberg as lead sponsor. Synced 16 Nov 2026
16Current trials
13Recruiting now
2Drugs in these trials
2Trial registers
At a glance

University Hospital Bispebjerg and Frederiksberg is the lead sponsor of 16 current clinical trials in our Denmark and Brazil registers. 13 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Lamotrigine and Lithium Carbonate. The most-studied condition is Atrial Fibrillation.

ClinicalTrials.gov trials by status

  • Recruiting1381%
  • Not yet open213%
  • Active, closed16%

Trials by phase

  • Not applicable956%
  • Observational638%
  • Phase 416%
01

Clinical trials sponsored by University Hospital Bispebjerg and Frederiksberg

16 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Brazilian Heart Insufficiency With Telemedicine
NCT04466852 · ClinicalTrials.gov ↗ · Heart Failure
Not applicable Recruiting 2020-08 Brazil
The Advance Project - Advancing Sleep Timing to Improve Depression
NCT06097221 · Depression
Not applicable Recruiting 2024-04 Denmark
Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate
NCT06405750 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Stroke
Not applicable Recruiting 2024-08 Denmark
Oral Health and Adverse Pregnancy Complications
NCT06110143 · ClinicalTrials.gov ↗ · Periodontal Diseases, Pregnancy Complications, Pregnancy Preterm
Not applicable Recruiting 2021-11 Denmark
Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia
NCT07189260 · ClinicalTrials.gov ↗ · Hip Fractures (ICD-10 72.01-72.2)
Not applicable Recruiting 2024-02 Denmark
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581 · ClinicalTrials.gov ↗ · Bipolar II Disorder
Phase 4 Recruiting 2024-05 Denmark
Weighted Blankets for Sleep Disturbance Among Children With ADHD
NCT06194162 · ClinicalTrials.gov ↗ · Attention-deficit Hyperactivity, Attention Deficit Hyperactivity Disorder, Neurodevelopmental Disorders
Not applicable Recruiting 2024-01 Denmark
The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure
NCT06176131 · ClinicalTrials.gov ↗ · Heart Failure,Congestive, Atrial Fibrillation
Observational Recruiting 2024-01 Denmark
Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons
NCT06142747 · ClinicalTrials.gov ↗ · Tendinopathy
Observational Recruiting 2024-02 Denmark
PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder
NCT06563466 · ClinicalTrials.gov ↗ · Borderline Personality Disorder, Relatives
Not applicable Recruiting 2024-09 Denmark
Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment
NCT07807228 · ClinicalTrials.gov ↗ · Atopic Dermatitis
Observational Recruiting 2025-06 Denmark
Retail-Grade Weighted Blanket Effectiveness on ADHD-related Sleep Disturbances (BEAD)
NCT07588659 · ADHD - Attention Deficit Disorder With Hyperactivity
Not applicable Recruiting 2026-08 Denmark
Medicines in Breast Milk and Estimated Infant Exposure
NCT07346716 · ClinicalTrials.gov ↗ · Breastfeeding, Medication Safety, Lactation
Observational Recruiting 2024-12 Denmark
Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.
NCT06628297 · ClinicalTrials.gov ↗ · Microvascular Disease, Microvascular Complications, Dementia
Observational Not yet open 2024-11 Denmark
Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion
NCT06624267 · ClinicalTrials.gov ↗ · Microvascular Disease, Microvascular Complications, Diabetes Mellitus Type 2
Observational Not yet open 2024-11 Denmark
STEPS: A Virtual Reality-based Intervention for Adults With Autism.
NCT06438536 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder
Not applicable Active, closed 2024-05 Denmark

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University Hospital Bispebjerg and Frederiksberg trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University Hospital Bispebjerg and Frederiksberg trials

30 conditions
Atrial Fibrillation2Microvascular Disease2Microvascular Complications2Diabetes Mellitus Type 22Depression1Stroke1Dementia1Periodontal Diseases1Pregnancy Complications1Pregnancy Preterm1Gestational Diabetes1Cerebral Hypoperfusion1Hip Fractures (ICD-10 72.01-72.2)1Bipolar II Disorder1Attention-deficit Hyperactivity1Attention Deficit Hyperactivity Disorder1Neurodevelopmental Disorders1Sleep Disturbance1Heart Failure,Congestive1Tendinopathy1Borderline Personality Disorder1Relatives1Atopic Dermatitis1Autism Spectrum Disorder1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Denmark1512
Clinical trials in Brazil11

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Atrial Fibrillation

SponsorTrials
Yonsei University12
Ottawa Heart Institute Research Corporation8
Biosense Webster7
Boston Scientific Corporation6
Volta Medical5
China National Center for Cardiovascular Diseases5
Population Health Research Institute4
Medtronic Cardiac Ablation Solutions4
Karolinska Institutet4
Insel Gruppe AG, University Hospital Bern4

Sponsors with the most current trials registered for this condition.

06

Questions about University Hospital Bispebjerg and Frederiksberg trials

How many clinical trials does University Hospital Bispebjerg and Frederiksberg sponsor?

University Hospital Bispebjerg and Frederiksberg is the lead sponsor of 16 current trials on ClinicalTrials.gov in our Denmark and Brazil registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are University Hospital Bispebjerg and Frederiksberg trials recruiting?

Yes. 13 of its 16 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University Hospital Bispebjerg and Frederiksberg testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Lamotrigine (1) and Lithium Carbonate (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.